Fasting

Time-restricted eating (TRE) and periodic fasting encompass a family of dietary patterns that limit caloric intake to a defined daily window , commonly 8 to 10 hours , without requiring calorie counting. While popularized as metabolic interventions, the evidence base as of 2025 shows meaningful but bounded benefits: measurable improvements in cardiometabolic risk factors, particularly for people with overweight or obesity, but modest differentiation from isocaloric caloric restriction alone. The strongest signal remains for people who are metabolically unhealthy at baseline.

Metabolic Mechanisms and Insulin Sensitivity {#metabolic-flexibility}

During fasting intervals, glycogen stores deplete and the body shifts toward fatty acid oxidation and ketone production , a state associated with improved insulin sensitivity and reduced fasting glucose. HOMA-IR, the standard clinical index of insulin resistance, falls consistently in TRE trials. A 2025 meta-analysis of 23 RCTs (Oxford Nutrition Reviews) found that 16/8 TRE produced significant reductions in fasting glucose, fasting insulin, and HOMA-IR compared to unrestricted eating controls. Early time-restricted feeding (eating window aligned with morning-to-afternoon circadian rhythm) appears to produce stronger insulin-sensitizing effects than late windows, likely because peripheral tissue insulin sensitivity peaks in the morning. However, a 2025 isocaloric trial (ChronoFast) cautioned that when calories are matched precisely, circadian clock shifts occur but cardiometabolic improvements are limited , suggesting some prior TRE benefits may be partly explained by spontaneous caloric reduction.

Cardiovascular Risk Factor Improvements {#cardiovascular-markers}

A 2025 systematic review and network meta-analysis of 56 RCTs (PMC 12289860) found that intermittent fasting reduced body weight, waist circumference, LDL cholesterol, fasting plasma glucose, and blood pressure compared to usual diet. Modified alternate-day fasting showed the highest effect sizes for systolic and diastolic blood pressure among the modalities tested. A 2025 Nutrition Journal meta-analysis (PMC 12309044) of 15 RCTs in overweight adults similarly confirmed reductions in body fat percentage, LDL, and fasting glucose, with effect sizes consistent across different TRE protocols. A 6-month Nature Communications RCT found an 8% reduction in body weight, 16% decrease in body fat, and significant LDL and triglyceride reductions in middle-aged adults with overweight. Importantly, a Lancet eClinicalMedicine umbrella review noted that head-to-head comparisons with continuous caloric restriction show comparable short-term outcomes , meaning IF works, but may not outperform equivalent caloric restriction for most cardiometabolic endpoints.

Weight and Body Composition {#weight-management}

Short-term TRE trials consistently show body weight reductions of 3–8% over 8–24 weeks, driven by a combination of reduced eating opportunity and altered appetite hormone dynamics (lower ghrelin, higher GLP-1 and PYY during fasting windows). The question of how much is mediated by spontaneous caloric intake reduction versus independent metabolic effects remains contested. Adherence to TRE is generally high in trials, with most participants successfully maintaining the eating window, making it a practical alternative to calorie counting for people who find portion-based restriction difficult. Long-term data beyond 12 months is limited.

Autophagy and Cellular Repair {#autophagy-cellular-repair}

Autophagy , the cellular recycling process that clears damaged proteins and organelles , is upregulated during nutrient deprivation. Nobel Prize-winning research by Yoshinori Ohsumi (2016) established the molecular mechanisms of autophagy in yeast, and subsequent human studies confirm measurable autophagy induction during extended caloric restriction. However, the threshold for meaningful autophagy activation in humans is substantially higher than what short TRE windows achieve: current evidence suggests a 16-hour daily fast produces limited autophagy flux relative to 24–72 hour extended fasts. The 16:8 pattern offers metabolic and cardiometabolic benefits, but claims of significant autophagy induction from daily TRE outpace the evidence. Autophagy-focused benefits appear more relevant to periodic longer fasts (36–72 hours) practiced monthly or quarterly, which remain harder to study in controlled RCT settings.